Ibrutinib-associated Serositis in Mantle Cell Lymphoma. (Record no. 29410133)

MARC details
000 -LEADER
fixed length control field 01473 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518024425.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1535-4970
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1164/rccm.201809-1738IM
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Styskel, Brett A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200224
245 00 - TITLE STATEMENT
Title Ibrutinib-associated Serositis in Mantle Cell Lymphoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. American journal of respiratory and critical care medicine
Date of publication, distribution, etc. 06 2019
300 ## - PHYSICAL DESCRIPTION
Extent e43-e44 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Mantle-Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Serositis
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lopez-Mattei, Juan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jimenez, Carlos A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stewart, John
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hagemeister, Fredrick B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Faiz, Saadia A
773 0# - HOST ITEM ENTRY
Title American journal of respiratory and critical care medicine
Related parts vol. 199
-- no. 12
-- p. e43-e44
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1164/rccm.201809-1738IM">https://doi.org/10.1164/rccm.201809-1738IM</a>
Public note Available from publisher's website

No items available.